Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › C13-substituted estra-1,3,5,(10)-trien-3-yl sulfamates, methods of preparing same, and pharmaceutical compositions containing these compounds

C13-substituted estra-1,3,5,(10)-trien-3-yl sulfamates, methods of preparing same, and pharmaceutical compositions containing these compounds

US Patent 6583130 · Granted Jun 24, 2003

Estimated economic value: $710,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted aminoquinolones as dgkalpha inhibitors for immune activation2025
Substituted aminoquinolones as DGKalpha inhibitors for immune activation2024
Antibody that binds CD269 (BCMA) suitable for use in the treatment of plasma cel2023
Antibody that binds CD269 (BCMA) suitable for use in the treatment of plasma cel2020
Benzimidazole derivatives as EP4 ligands2020
Heterocyclylmethyl-thienouracile as antagonists of the adenosine-A2B-receptor2019
Pro-drug forming compounds2019
Antibody that binds CD269 (BCMA) suitable for use in the treatment of plasma cel2019
4-aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group2018
Fluorinated benzofuranyl-pyrimidine derivatives containing a sulfone group2018
Fluorinated benzofuranyl-pyrimidine derivatives containing a sulfoximine group2018
5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine gr2018